Financials
- Market Capitalization 1.56 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-79.2
Relación precio/flujo de caja
4.13
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2160 | AAPG Ascentage Pharma Group International - American Depository Shar | 16.64 USD | +2.53% | -1.13% | -5.19% | -33.44% | 1.55 B USD | ||
| 2165 | INVA Innoviva, Inc. - Common Stock | 21.36 USD | +1.33% | +0.56% | +1.86% | +19.87% | 1.54 B USD | ||
| 2170 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.55 USD | +0.56% | -4.77% | -12.29% | +63.09% | 1.56 B USD | ||
| 2187 | REPL Replimune Group, Inc. - Common Stock | 15.98 USD | +1.98% | +0.63% | +45.27% | +168.12% | 1.51 B USD |